Bionexus Foundation

“Raymond cypess, heather kiessling, melissa rewolinski, scott boller, therese sellars, and ruth cheng, directors and/or officers of bionexus, had a business relationship during the tax year; they all served as directors and/or officers of atcc cell systems, inc., a related party as discussed on schedule r. Raymond cypess, scott boller, and therese sellars also served as directors of bio essentials ltd., a related party as discussed on schedule r.”

“Bionexus foundation ("bionexus") is a corporation established under the district of columbia non-profit corporation act. It has one corporate member, atcc global, which is tax exempt under 501(c)(3) and is a type ii supporting organization under 509(a)(3). Atcc global has the right to elect bionexus' board of directors and to vote in any corporate proceeding which is submitted to a vote of the corporate membership. Bionexus' board of directors has the authority to manage the business and do all such lawful acts and things as are not prohibited by statute or by the articles of incorporation or bionexus' bylaws. Any modifications to the articles of incorporation or bylaws require the approval of atcc global.”

“The form 990 is prepared by pwc us tax llp ("pwc"), based on the information provided by the organization's staff. Prior to filing with the irs, the form 990 is made available to the board, pwc signs as preparer and the chief financial officer signs on behalf of the organization.”

“Bionexus has a conflict of interest policy that requires officers and directors to disclose annually, interests that could give rise to conflicts. This policy is consistently monitored and enforced. Board members who have a conflict of interest do not vote on any matter related to the issue for which they have a potential conflict. Conflict of interest forms are distributed to, and signed by, the members of the board, and then returned to outside counsel for review. Disclosed conflicts, if any, are assessed by outside counsel, and outside counsel assists with any necessary follow-up activities.”

“Atcc, a related organization, pays compensation for all bionexus foundation's officers and employees. Atcc global determines the compensation processes for all related entities. The compensation committee of the atcc global board of directors reviews and gives final approvalfor the overall compensation programs for atcc.. These programs may include salary structures, merit increases, bonuses and benefits, as well as market and range adjustments. The executive committee reviews and approves compensation for the ceo and executives using data for similarly qualified persons in functionally comparable positions within similar industries. Documentation of such discussions and decisions, as well as related approvals are provided by the vp, human resources/chief people officer for recordkeeping. A third-party analysis of total executive compensation was completed in december 2022. The next review is scheduled for late 2025/early 2026.”

“The organization does not make its governing documents, conflict of interest policy, or financial statements available to the public.”